Long-term outcomes with emicizumab prophylaxis for severe haemophilia a without fviii inhibitors: efficacy and safety analyses from haven 3 & 4J. Mahlangu,V. Jimenez-Yuste, G. Ventriglia,M. Niggli, S. Barlera,C. Hermans,M. Lehle,P. Chowdary, L. Jew,J. Windyga,L. Frenzel,G. Castaman,S. W. PipeHAEMOPHILIA（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
